Literature DB >> 3130358

The dynamics of tumor cords in an irradiated mouse mammary carcinoma with a large hypoxic cell component.

J V Moore1.   

Abstract

The tumor cord model represents a histologically based framework for interpretation of radiobiological phenomena, particularly the resistance to radiation conferred by absence of oxygen. For the mammary carcinoma T50/80 grown in B6D2F1 male mice, average oxygenation was poor, based on tumor growth delay after irradiation. There was no improvement in radiobiological oxygenation for several days after a high dose of radiation. This was consistent with events in the cords of the tumor, where although up to 20% of all cells became pyknotic by 8 hr, the cords did not shrink for at least 2 days. The cellular kinetics of populations of intact and dead cells, adjacent to and remote from the capillaries of the cords, were examined for up to 60 hr after irradiation and it was found that: (i) before treatment, average LI (adjacent) was 13% and LI (remote) was 2%, (ii) after irradiation, cells expressed pyknosis after passing through the S phase of the cell cycle, so that (iii) at early intervals there was a larger proportional rise in pyknotic cells in the adjacent than the remote zone. However, (iv) at later intervals there was always a higher proportion of dead cells in the remote zone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130358      PMCID: PMC5917465          DOI: 10.1111/j.1349-7006.1988.tb01582.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  11 in total

1.  Some aspects of the effect of ionizing radiation on tumors in experimental animals.

Authors:  O C SCOTT
Journal:  Adv Biol Med Phys       Date:  1958

2.  The response of viable tumor cords to a single dose of radiation.

Authors:  I Tannock; A Howes
Journal:  Radiat Res       Date:  1973-09       Impact factor: 2.841

3.  An estimation of changes in the proportions and absolute numbers of hypoxic cells after irradiation of transplanted C3H mousemammary tumours.

Authors:  A E Howes
Journal:  Br J Radiol       Date:  1969-06       Impact factor: 3.039

4.  Tumor regrowth after irradiation; an experimental approach.

Authors:  H Yamaura; T Matsuzawa
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-03

5.  Post-irradiation kinetics of the C3H/He mouse mammary carcinoma as regards tumor volume regrowth time and cell loss.

Authors:  N Tanaka; C Tanabe; Y Okumura; K Murakami
Journal:  Strahlentherapie       Date:  1979-01

6.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

7.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

8.  The gross response of an experimental tumour to single doses of x-rays.

Authors:  R H Thomlinson; E A Craddock
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

9.  Tumour cords in 52 human bronchial and cervical squamous cell carcinomas: inferences for their cellular kinetics and radiobiology.

Authors:  J V Moore; P S Hasleton; C H Buckley
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

10.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

View more
  8 in total

1.  The effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae.

Authors:  D T Griffin; N J Dodd; J V Moore; B R Pullan; T V Taylor
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

2.  The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N.

Authors:  R Gallagher; C M Hughes; M M Murray; O P Friery; L H Patterson; D G Hirst; S R McKeown
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

3.  Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.

Authors:  O P Friery; R Gallagher; M M Murray; C M Hughes; E S Galligan; I A McIntyre; L H Patterson; D G Hirst; S R McKeown
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

4.  Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.

Authors:  L H Patterson; S R McKeown; K Ruparelia; J A Double; M C Bibby; S Cole; I J Stratford
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

5.  Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data.

Authors:  L T Baxter; R K Jain
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

6.  AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo.

Authors:  S R McKeown; M V Hejmadi; I A McIntyre; J J McAleer; L H Patterson
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

7.  DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.

Authors:  M V Hejmadi; S R McKeown; O P Friery; I A McIntyre; L H Patterson; D G Hirst
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

8.  The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.

Authors:  M P MacManus; A P Maxwell; W P Abram; J M Bridges
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.